Second generation antipsychotics causing neuroleptic malignant syndrome

dc.contributor.authorSuraweera, C.
dc.contributor.authorHanwella, Raveen
dc.contributor.authorDe Silva, V.
dc.date.accessioned2026-01-14T06:07:14Z
dc.date.issued2016
dc.description.abstractNeuroleptic malignant syndrome (NMS) is a rare yet potentially lethal medical emergency encountered by psychiatrists. NMS is commonly associated with potent first generation antipsychotics, especially haloperidol and fluphenazine. However, there are many case reports of NMS caused by treatment with second generation antipsychotics (SGA). Mortality from NMS caused by SGA may be less and the presentation may also be different. The article discusses two case reports of neuroleptic malignant syndrome caused by SGA both of which have some unusual features.
dc.identifier.citationSuraweera, C., Hanwella, R., & De Silva, V. (2016). Second generation antipsychotics causing neuroleptic malignant syndrome. Sri Lanka Journal of Psychiatry, 7(2), 20-22. https://doi.org/10.4038/sljpsyc.v7i2.8115
dc.identifier.doi10.4038/sljpsyc.v7i2.8115
dc.identifier.urihttps://doi.org/10.4038/sljpsyc.v7i2.8115
dc.identifier.urihttps://archive.cmb.ac.lk/handle/70130/8449
dc.language.isoen
dc.publisherSri Lanka Journal of Psychiatry
dc.relation.ispartofSri Lanka Journal of Psychiatry
dc.subjectNeuroleptic malignant syndrome
dc.subjectFirst generation antipsychotics
dc.subjectSecond generation antipsychotics
dc.titleSecond generation antipsychotics causing neuroleptic malignant syndrome
dc.typeArticle
oaire.citation.issue2
oaire.citation.volume7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Second generation antipsychotics causing neuroleptic malignant syndrome.pdf
Size:
51.75 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections